Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the…
Hepatitis C Marianne Martinello, PhD et al. Summary Hepatitis C virus (HCV) is a hepatotropic RNA virus that can cause…
Hepatitis D Virus Infection Tarik Asselah and Mario Rizzetto Hepatitis D virus (HDV), also known as hepatitis delta virus, is…
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept Alessandro Vitale e HCC Special Interest Group of the…
Diagnosis and Management of Cirrhosis and Its Complications. A Review Elliot B. Tapper, Neehar D. Parikh, Abstract Importance Cirrhosis affects approximately 2.2…
Mortality Outcomes by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis Cheng Han Ng et al.…
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial Mads Israelsen…
Acute Kidney Injury in Patients with Cirrhosis Mitra K. Nadim, M.D., and Guadalupe Garcia-Tsao Acute kidney injury (AKI) is a common…
Management of Hepatocellular Carcinoma. A Review Zachary J. Brown et al. Abstract Importance Hepatocellular carcinoma (HCC) is the sixth most common malignancy…
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European…
Aspirin With or Without Statin in Individuals Without Atherosclerotic Cardiovascular Disease Across Risk Categories Safi U. Khan et al Abstract…
Systematic Review and Meta-Analysis on the Effects of Lactulose and Rifaximin on Patient-Reported Outcomes in Hepatic Encephalopathy Andrew M. Moon…
Altered Microbiota in Cirrhosis and Its Relationship to the Development of Infection Jasmohan S. Bajaj Figure 1 Changes in…
New Approaches to Chronic Hepatitis B Geoffrey Dusheiko et al. Chronic hepatitis B is caused by the hepatitis B virus…
L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial Arpan Jainet al. Abstract Background and…
A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study Andrew Fagan et al. Highlights •…
Early Diagnosis and Prevention of Infections in Cirrhosis Anand V. Kulkarn et al. Abstract Strategies to prevent infection and improve…
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis Elisa Pose, et al. Abstract…
Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis Masahide Enomoto et al.…
Rifaximin for the prevention and treatment of hepatic encephalopathy: a systematic review and meta-analysis of randomized clinical trials Harry Demetrios…
Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multi-center Inpatient Cirrhosis Cohort Jasmohan S Bajaj et al.…
Update on the management of gastrointestinal varices Umesha Boregowda et al. Abstract Cirrhosis of liver is a major problem in…
Baveno VII – Renewing consensus in portal hypertension Roberto de Franchis et al. Summary To expand on the work of…
Hepatic encephalopathy: Thinking Beyond ammonia Hanna Blaney, M.D., M.P.H.,* and Sharon DeMorrow, Ph.D Hepatic encephalopathy (HE) is a syndrome of…